Kidney Transplant Market Expands as Major Companies Astellas Pharma, Teva Pharmaceuticals, and AbbVie Focus on Advanced Post-Transplant Care
The global kidney transplant market was valued at USD 81.0 billion in 2023 and is projected to reach USD 116.4 billion by the end of 2034. The industry is expected to grow at a CAGR of 3.3% from 2024 to 2034, driven by the rising prevalence of chronic kidney diseases, increasing organ transplantation procedures, advancements in immunosuppressive therapies, and improved healthcare...
0 Commenti 0 condivisioni 110 Views 0 Anteprima